Crossref
Serum Endocan Levels in Adult Asthma Patients: A Controlled Study Investigating Associations With Disease Severity and Asthma Control
Asthma Allergy Immunology · 23.12.2025 · 23 (3) · 233-241
DOI: 10.21911/aai.2025.841 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asthma Allergy Immunology, online erschienen am 23.12.2025. Verfasst von Aydın COL und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
COL, A., YAZICI, O., & YENISEY, C. (2025). Serum Endocan Levels in Adult Asthma Patients: A Controlled Study Investigating Associations With Disease Severity and Asthma Control. Asthma Allergy Immunology, 23(3), 233-241. https://doi.org/10.21911/aai.2025.841
Vancouver
COL A, YAZICI O, YENISEY C. Serum Endocan Levels in Adult Asthma Patients: A Controlled Study Investigating Associations With Disease Severity and Asthma Control. Asthma Allergy Immunology. 2025;23(3):233-241. doi:10.21911/aai.2025.841
BibTeX
@article{COL2025,
author = {COL, Aydın and YAZICI, Onur and YENISEY, Cigdem},
title = {Serum Endocan Levels in Adult Asthma Patients: A Controlled Study Investigating Associations With Disease Severity and Asthma Control},
journal = {Asthma Allergy Immunology},
year = {2025},
volume = {23},
number = {3},
pages = {233--241},
doi = {10.21911/aai.2025.841}
}
EUVIMED